marijuana stock news

Canopy Growth to Report First Quarter Fiscal 2021 Financial Results on August 10, 2020

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the first quarter fiscal 2021 ended June 30, 2020 before financial markets open on August 10, 2020.

Following the release of its first quarter fiscal 2021 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on August 10, 2020.

Webcast Information
A live audio webcast will be available at:
https://produceredition.webcasts.com/starthere.jsp?ei=1343663&tp_key=96c72fd568

Replay Information
A replay will be accessible by webcast until 11:59 PM ET on November 8, 2020 at:
https://produceredition.webcasts.com/starthere.jsp?ei=1343663&tp_key=96c72fd568

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. For more information visit www.canopygrowth.com

More

View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-report-first-quarter-fiscal-2021-financial-results-on-august-10-2020-301103482.html

SOURCE Canopy Growth Corporation


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CBIS Set to Release Seven Cannabinoid-Based Animal Care Products

With Product & Market Testing Completed, Cannabis Science Set to Release Seven…

 Lexaria Bioscience Corp. (LXRP) Applies for NIH Grant for COVID-19 Therapy Studies

Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives…

$ENRT signed with London Drugs: V-Love ™ to be in stores soon

Enertopia signed with London Drugs: V-Love ™ to be in stores soon…

InMed Pharmaceuticals Inc. (IMLFF) Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755

InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate –…